安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CAR 安飞士

盘后交易 06-24 17:31:32 EDT

175.29

-15.17

-7.96%

盘后176.00

+0.71+0.41%

17:23 EDT

最高186.58	最低174.45	成交量63.39万
今开183.88	昨收190.46	日振幅6.37%
总市值61.92亿	流通市值25.89亿	总股本3,532万
成交额1.13亿	换手率4.29%	流通股本1,477万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CAR","market":"US","secType":"STK","nameCN":"安飞士","latestPrice":175.29,"timestamp":1782331200000,"preClose":190.46,"halted":0,"volume":633903,"hourTrading":{"tag":"盘后","latestPrice":176,"preClose":175.29,"latestTime":"17:23 EDT","volume":9149,"amount":1603995.1778199999,"timestamp":1782336200964,"change":0.71,"changeRate":0.00405,"amplitude":0.007559},"delay":0,"changeRate":-0.07964927018796605,"floatShares":14770456,"shares":35324685,"eps":-18.935415,"marketStatus":"盘后交易","change":-15.17,"latestTime":"06-24 17:31:32 EDT","open":183.88,"high":186.58,"low":174.45,"amount":113395319.77902001,"amplitude":0.063688,"askPrice":177.5,"askSize":1,"bidPrice":176,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-18.935415,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1782345600000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":190.46,"preHourTrading":{"tag":"盘前","latestPrice":185,"preClose":190.46,"latestTime":"09:29 EDT","volume":5088,"amount":957521.60832,"timestamp":1782307799999,"change":-5.46,"changeRate":-0.028667,"amplitude":0.045364},"postHourTrading":{"tag":"盘后","latestPrice":176,"preClose":175.29,"latestTime":"17:23 EDT","volume":9149,"amount":1603995.1778199999,"timestamp":1782336200964,"change":0.71,"changeRate":0.00405,"amplitude":0.007559},"volumeRatio":1.259714,"impliedVol":0.6391,"impliedVolPercentile":0.7291},"requestUrl":"/m/hq/s/CAR/wiki","defaultTab":"wiki","newsList":[{"id":"1183485949","title":"异动解读｜安飞士盘中下跌5.4%，报174.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183485949","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183485949?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:05","pubTimestamp":1782309950,"startTime":"0","endTime":"0","summary":"6月24日，安飞士盘中下跌5.4%，报174.61美元/股，成交额1983.15万美元。安飞士所在的旅客陆运行业中，个股表现分化，其中优步涨0.89%，Lyft涨1.09%，Grab Holdings跌0.72%，Marti Technologies跌5.8%，赫兹租车跌26.86%。安飞士成立于1946年，是一家全球领先的车辆租赁和汽车共享服务提供商，通过Avis、Budget和Zipcar运营着业内最受认可的三个品牌，是北美、欧洲、澳大利亚、新西兰和某些地区领先的车辆租赁运营商。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645816243","title":"赫兹全球控股提交最高1亿美元的增发申请后，安飞士预算集团股价下跌7.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816243","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645816243?lang=zh_cn&edition=full","pubTime":"2026-06-24 22:02","pubTimestamp":1782309776,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4022","BK4230","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174064426","title":"异动解读｜安飞士盘中上涨5.21%，与Pentwater资本管理公司达成6.5亿美元和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1174064426","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174064426?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:53","pubTimestamp":1782226429,"startTime":"0","endTime":"0","summary":"6月23日，安飞士盘中上涨5.21%，报194.05美元/股，成交额3589.95万美元。消息面上，安飞士预算集团已于6月19日与Pentwater资本管理公司及其关联方签署和解及免责协议，以6.5亿美元现金和解方式了结其对Pentwater提起的短线交易利润追回诉讼。该和解金额须经法院批准，包括确认公司已积极追诉相关索赔、和解金额公平充分等常规条件。此举标志着双方法律争议告一段落，解决与主要投资机构间的纠纷有助于管理层更专注于公司核心运营与长期战略发展，市场对此反应积极。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158355909","title":"异动解读｜安飞士盘前上涨7.37%，与Pentwater资本管理公司达成6.5亿美元和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158355909","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158355909?lang=zh_cn&edition=full","pubTime":"2026-06-23 19:31","pubTimestamp":1782214263,"startTime":"0","endTime":"0","summary":"6月23日，安飞士盘前上涨7.37%，报200.0美元/股，成交额18.91万美元。消息面上，安飞士预算集团已于6月19日与Pentwater资本管理公司及其关联方签署和解及免责协议，以6.5亿美元现金和解方式了结其对Pentwater提起的短线交易利润追回诉讼。该和解金额须经法院批准，包括确认公司已积极追诉相关索赔、和解金额公平充分等常规条件。此举标志着双方法律争议告一段落，解决与主要投资机构间的纠纷有助于管理层更专注于公司核心运营与长期战略发展，市场对此反应积极。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117708113","title":"异动解读｜安飞士夜盘上涨5.22%，与Pentwater资本管理公司达成6.5亿美元和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1117708113","media":"行情直击","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117708113?lang=zh_cn&edition=full","pubTime":"2026-06-23 08:53","pubTimestamp":1782175983,"startTime":"0","endTime":"0","summary":"6月23日，安飞士夜盘上涨5.22%，报196.0美元/股，成交额1960.0美元。消息面上，安飞士预算集团已于6月19日与Pentwater资本管理公司签署和解协议，以6.5亿美元现金和解方式了结其对Pentwater提起的短线交易利润追回诉讼。该和解金额须经法院批准，包括确认协议条款合理充分等常规条件。此举标志着双方法律争议告一段落，解决与主要投资机构间的纠纷有助于管理层更专注于公司核心运营与长期战略发展，市场对此反应积极。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158327738","title":"安飞士预算集团股价盘后交易量相对清淡中攀升6.9%至199.09美元，宣布与Pentwater资本管理达成和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1158327738","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158327738?lang=zh_cn&edition=full","pubTime":"2026-06-23 05:12","pubTimestamp":1782162756,"startTime":"0","endTime":"0","summary":"安飞士预算集团股价在盘后交易时段上涨6.9%，收于199.09美元，尽管交易量相对清淡。公司同时宣布，已与Pentwater资本管理公司达成一项和解协议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","CAR","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188628104","title":"异动解读｜安飞士盘后上涨6.83%，与Pentwater资本管理公司达成和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1188628104","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188628104?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:35","pubTimestamp":1782160516,"startTime":"0","endTime":"0","summary":"6月22日，安飞士盘后上涨6.83%，报200.0美元/股，成交额134.29万美元。消息面上，安飞士预算集团已于6月19日与Pentwater资本管理公司签署和解协议，相关细节已通过美国证券交易委员会文件予以披露。此举标志着双方之间潜在争议告一段落，解决与主要投资机构之间的纠纷有助于管理层更专注于公司核心运营与长期战略发展，市场对此反应积极。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143586766","title":"安飞士预算集团与Pentwater资本管理公司达成和解协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1143586766","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143586766?lang=zh_cn&edition=full","pubTime":"2026-06-23 04:33","pubTimestamp":1782160421,"startTime":"0","endTime":"0","summary":"安飞士预算集团已于2026年6月19日与Pentwater资本管理公司签署了一项和解协议。该协议的相关细节已通过美国证券交易委员会的文件予以披露。\n此举标志着双方之间可能存在的争议或法律程序告一段落。此类和解通常涉及双方就特定条款达成一致，以避免进一步的诉讼或冲突。对于安飞士预算集团而言，解决与主要投资机构之间的潜在纠纷，有助于管理层更专注于公司的核心运营与长期战略发展。\n市场参与者通常关注此类和解协议，因其可能影响公司治理、股东关系乃至未来的财务表现。协议的最终条款及其对公司的具体影响，有待后续更详细的公开信息进一步阐明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","CAR","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645022657","title":"全球首个实体瘤CAR-T细胞药物获批上市，成本有望降到几万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645022657","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645022657?lang=zh_cn&edition=full","pubTime":"2026-06-22 20:15","pubTimestamp":1782130500,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯（记者俞金旻）6月22日，国家药品监督管理局通过优先审评审批程序批准，恺兴生命科技（上海）有限公司申报的舒瑞基奥仑赛注射液（商品名：恺力美）上市。据企查查，恺兴生命科技（上海）有限公司注册地为上海浦东，是科济药业控股有限公司旗下公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606223778259922.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223778259922.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4230","BK4022","IPOS","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645400610","title":"科济药业：自研CAR-T细胞治疗产品恺力美获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2645400610","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645400610?lang=zh_cn&edition=full","pubTime":"2026-06-22 16:53","pubTimestamp":1782118380,"startTime":"0","endTime":"0","summary":"6月22日，科济药业（02171）发布公告，国家药品监督管理局批准公司自主研发的Claudin18.2自体人源化CAR-T细胞治疗产品恺力美?（舒瑞基奥仑赛注射液）的新药上市申请。公告指出，恺力美?用于治疗Claudin18.2阳性、人表皮生长因子受体2（HER2）阴性，至少二线治疗失败的晚期胃/食管胃结合部腺癌。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223778072646.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1585","BK4230","CAR","BK1574","02171","BK4022","BK1161","BK1587","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645414460","title":"“百万元一针”抗癌药有望降至万元，科济药业研发通用型CAR-T疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=2645414460","media":"上观新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645414460?lang=zh_cn&edition=full","pubTime":"2026-06-22 14:57","pubTimestamp":1782111437,"startTime":"0","endTime":"0","summary":"科济药业创始人、首席执行官李宗海博士介绍，科济药业已将研发重心从自体CAR-T（嵌合抗原受体T细胞）转向通用型CAR-T疗法。自体CAR-T疗法利用人体自身免疫系统开展个体化治疗：先通过白细胞分离，从患者体内提取T细胞；再用CAR（嵌合抗原受体）对其修饰，让T细胞能识别癌细胞上特定抗原；完成基因工程修饰后，将CAR-T制剂回输给这名患者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606223777971181.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4230","BK1161","02171","BK1587","BK1574","BK1585","CAR","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117946131","title":"异动解读｜安飞士盘中上涨5.32%，报190.5美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117946131","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117946131?lang=zh_cn&edition=full","pubTime":"2026-06-19 02:55","pubTimestamp":1781808924,"startTime":"0","endTime":"0","summary":"6月18日，安飞士盘中上涨5.32%，报190.5美元/股，成交额1.1亿美元。安飞士所在的旅客陆运行业中，个股表现分化，其中赫兹租车涨3.52%，Grab Holdings涨3.19%，优步涨1.11%，Lyft涨0.85%，Wetour Robotics Limited跌8.56%。安飞士成立于1946年，是一家全球领先的车辆租赁和汽车共享服务提供商，通过Avis、Budget和Zipcar运营着业内最受认可的三个品牌，是北美、欧洲、澳大利亚、新西兰和某些地区领先的车辆租赁运营商。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643495892","title":"金斯瑞生物科技(01548)：传奇潜在“同类首创”体内CD19/CD20双靶点CAR-T疗法LB2501在复发/难治性B细胞非霍奇金淋巴瘤中获得临床概念验证","url":"https://stock-news.laohu8.com/highlight/detail?id=2643495892","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643495892?lang=zh_cn&edition=full","pubTime":"2026-06-14 18:18","pubTimestamp":1781432300,"startTime":"0","endTime":"0","summary":"智通财经APP讯，金斯瑞生物科技 发布公告，本公司联营公司传奇生物科技股份有限公司于2026年6月14日发布新闻稿，宣布其针对复发/难治性B细胞非霍奇金淋巴瘤患者的在研体内CD19/CD20双靶点CAR-T细胞疗法LB2501首次临床概念验证数据。在这项正在开展的I期研究中，单次输注LB2501在无需进行淋巴细胞清除的情况下，实现了体内CAR-T细胞的剂量依赖性扩增。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4022","BK4230","HK0000320223.HKD","HK0000306701.USD","01548","CAR","BK1141","HK0000306685.HKD","HK0000320264.USD","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129455475","title":"异动解读｜安飞士盘中上涨5.21%，获巴克莱上调评级至同等权重","url":"https://stock-news.laohu8.com/highlight/detail?id=1129455475","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129455475?lang=zh_cn&edition=full","pubTime":"2026-06-08 21:54","pubTimestamp":1780926890,"startTime":"0","endTime":"0","summary":"6月8日，安飞士盘中上涨5.21%，报184.7美元/股，成交额2124.66万美元。消息面上，巴克莱将安飞士评级从\"跑输大盘\"上调至\"同等权重\"，同时将目标价从140美元上调至160美元。此次巴克莱上调评级释放了对公司基本面边际改善的积极信号，推动股价走强。同行业中，赫兹租车同日上涨4.32%，租车板块整体表现活跃。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641122909","title":"医药生物行业：重磅数据公布 体内CAR-T风起","url":"https://stock-news.laohu8.com/highlight/detail?id=2641122909","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641122909?lang=zh_cn&edition=full","pubTime":"2026-06-07 01:17","pubTimestamp":1780766222,"startTime":"0","endTime":"0","summary":"　　事件：5 月31 日，Kelonia Therapeutics 在ASCO2026 上公布了其在研体内BCMA CAR-T 疗法KLN-1010 针对复发/难治性多发性骨髓瘤患者的I 期inMMyCAR 研究最新数据，引发全场瞩目。无独有偶，6 月2 日，传奇生物宣布，将在6 月11 日至6 月14 日召开的 EHA会议上，以最新突破口头汇报的形式，首次公布CD19/CD20双靶点体内CAR-T 疗法LB2501 在复发/难治性B 细胞非霍奇金淋巴瘤患者中的初步临床数据，市场反馈积极。　　LB2501：重磅摘要结果公布，提前锁定EHA LBA 席位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260607/32272161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["000808.SH","CAR","BK4230","BK4022","163118"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640914427","title":"石药集团(01093)开发的首款基于mRNA-LNP的双靶点CAR -T细胞注射液(SYS 6063注射液)在中国获临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2640914427","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640914427?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:23","pubTimestamp":1780395806,"startTime":"0","endTime":"0","summary":"智通财经APP讯，石药集团 公布，集团开发的首款基于mRNA-LNP的双靶点嵌合抗原受体-T细胞注射液，已获中华人民共和国国家药品监督管理局批准，可在中国开展临床试验。产品为全球首款获批临床试验的基于mRNA-LNP的双靶点细胞治疗产品，通过表达可特异性识别白细胞分化抗原19与B细胞成熟抗原的CAR，精准识别并清除患者体内CD19和BCMA阳性的细胞，从而达到治疗目的。临床前研究显示，该产品可显著杀伤CD19和BCMA阳性细胞，并具有良好的安全性和有效性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449164.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BZ08YR35.GBP","LU1152091754.HKD","IE00BZ08YT58.USD","LU1328277881.USD","LU1226287792.SGD","CAR","IE00B543WZ88.USD","LU0315179316.USD","SG9999004220.SGD","IE00B031HY20.USD","BK4230","LU0501845795.SGD","IE0008369823.USD","LU0067412154.USD","LU1960683339.HKD","LU1951186391.HKD","HK0000165453.HKD","LU0326950275.SGD","LU0880133367.SGD","BK1191","LU1813983027.USD","LU2039709279.SGD","LU1807302812.USD","LU0072913022.USD","LU0140636845.USD","IE00BZ08YS42.EUR","BK1521","LU1226287875.USD","LU1226287529.USD","01093","BK4022","LU0314109678.HKD","LU1226288253.USD","LU1226288170.HKD","IE00B5MMRT66.SGD","IE0008368742.USD","BK1515","LU1008478684.HKD","LU1152091168.USD","LU1993786604.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103560548","title":"异动解读｜安飞士盘中上涨5.18%，逼空行情叠加债务优化举措延续强势","url":"https://stock-news.laohu8.com/highlight/detail?id=1103560548","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103560548?lang=zh_cn&edition=full","pubTime":"2026-05-28 21:58","pubTimestamp":1779976693,"startTime":"0","endTime":"0","summary":"5月28日，安飞士盘中上涨5.18%，报172.95美元/股，成交额1127.88万美元。消息面上，该股近期持续受逼空行情驱动，多空博弈剧烈。与此同时，公司宣布完成3亿美元2031年到期8%优先票据定价，所得净收益将用于部分赎回2027年到期的5.75%优先票据，旨在优化债务结构、降低近期偿债压力并提升财务灵活性。此外，公司终止与Verra Mobility的合同也引发市场关注。同板块中，赫兹租车涨0.95%，行业内租车股呈现一定联动。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113269464","title":"安飞士预算集团拟发行3亿美元优先票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1113269464","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113269464?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:55","pubTimestamp":1779882950,"startTime":"0","endTime":"0","summary":"安飞士预算集团宣布，计划发行总额3亿美元的优先票据。该公司表示，计划将此次发行所得的净收益及现有现金，用于赎回部分将于2027年到期的5.75%优先票据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","BK4022","CAR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143802389","title":"安飞士预算集团拟动用净收益及现金赎回部分2027年到期5.75%优先票据","url":"https://stock-news.laohu8.com/highlight/detail?id=1143802389","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143802389?lang=zh_cn&edition=full","pubTime":"2026-05-27 19:37","pubTimestamp":1779881834,"startTime":"0","endTime":"0","summary":"安飞士预算集团宣布，将利用近期融资所得净收益及公司自有现金，部分赎回其2027年到期的5.75%优先票据。此举旨在优化公司债务结构，管理利息支出，并提升财务灵活性。通过提前赎回部分高息债务，公司有望降低整体融资成本，并强化资产负债表。市场分析认为，这一主动的债务管理举措反映了公司稳健的现金流状况以及对未来财务健康的积极规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","CAR","BK4022"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142966379","title":"异动解读｜安飞士盘中上涨5.55%，报175.5美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142966379","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142966379?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:01","pubTimestamp":1779804062,"startTime":"0","endTime":"0","summary":"5月26日，安飞士盘中上涨5.55%，报175.5美元/股，成交额3153.46万美元。安飞士所在的旅客陆运行业中，个股表现分化，其中赫兹租车涨6.31%，Grab Holdings涨1.99%，Lyft, Inc.跌0.4%，优步跌2.1%，Wetour Robotics Limited跌7.48%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.avisbudgetgroup.com","stockEarnings":[{"period":"1week","weight":0.0268},{"period":"1month","weight":0.1401},{"period":"3month","weight":0.5414},{"period":"6month","weight":0.4448},{"period":"1year","weight":0.2956},{"period":"ytd","weight":0.4843}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0162},{"period":"3month","weight":0.1169},{"period":"6month","weight":0.0626},{"period":"1year","weight":0.2223},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Avis Budget Group, Inc.成立于1946年，是一家全球领先的车辆租赁和汽车共享服务提供商，通过Avis、Budget和Zipcar运营着业内最受认可的三个品牌。该公司是北美、欧洲、澳大利亚、新西兰和某些地区领先的车辆租赁运营商。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.011725},{"month":2,"riseRate":0.5625,"avgChangeRate":0.031733},{"month":3,"riseRate":0.625,"avgChangeRate":0.065494},{"month":4,"riseRate":0.6875,"avgChangeRate":0.039277},{"month":5,"riseRate":0.4375,"avgChangeRate":0.012213},{"month":6,"riseRate":0.5625,"avgChangeRate":0.036535},{"month":7,"riseRate":0.6,"avgChangeRate":0.040059},{"month":8,"riseRate":0.4,"avgChangeRate":-0.00977},{"month":9,"riseRate":0.466667,"avgChangeRate":-0.027276},{"month":10,"riseRate":0.666667,"avgChangeRate":0.119671},{"month":11,"riseRate":0.666667,"avgChangeRate":0.07647},{"month":12,"riseRate":0.4,"avgChangeRate":-0.047503}],"exchange":"NASDAQ","name":"安飞士","nameEN":"Avis Budget"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安飞士(CAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安飞士,CAR,安飞士股票,安飞士股票老虎,安飞士股票老虎国际,安飞士行情,安飞士股票行情,安飞士股价,安飞士股市,安飞士股票价格,安飞士股票交易,安飞士股票购买,安飞士股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安飞士(CAR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安飞士(CAR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}